What is the most common side effect associated with IV amphotericin B use?

Prepare for the KMK Live Session General Pharmacy Test. Use flashcards and multiple-choice questions with hints and explanations for each question. Get ready for your exam with confidence!

Multiple Choice

What is the most common side effect associated with IV amphotericin B use?

Explanation:
Nephrotoxicity is the most common adverse effect of intravenous amphotericin B. The drug can interact with cholesterol in human cell membranes, including kidney cells, leading to direct tubular toxicity and afferent arteriolar vasoconstriction. This combination reduces the glomerular filtration rate and causes electrolyte losses (notably potassium and magnesium), making kidney injury the dose-limiting toxicity of amphotericin B. In contrast, while liver toxicity, neurotoxicity, or cardiotoxicity can occur, they are far less common with standard IV use. Strategies to lessen nephrotoxicity include pre- and post-infusion hydration, avoiding other nephrotoxins, and using liposomal or lipid formulations when possible, which are associated with lower risk to the kidneys. Monitoring renal function and electrolytes is essential during therapy.

Nephrotoxicity is the most common adverse effect of intravenous amphotericin B. The drug can interact with cholesterol in human cell membranes, including kidney cells, leading to direct tubular toxicity and afferent arteriolar vasoconstriction. This combination reduces the glomerular filtration rate and causes electrolyte losses (notably potassium and magnesium), making kidney injury the dose-limiting toxicity of amphotericin B.

In contrast, while liver toxicity, neurotoxicity, or cardiotoxicity can occur, they are far less common with standard IV use. Strategies to lessen nephrotoxicity include pre- and post-infusion hydration, avoiding other nephrotoxins, and using liposomal or lipid formulations when possible, which are associated with lower risk to the kidneys. Monitoring renal function and electrolytes is essential during therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy